Why Biden is invoking the Defense Production Act to alleviate formula shortage

US ramping up formula production, authorizing flights to import supplies from overseas
baby formula
Photo credit Getty Images
By , KYW Newsradio

PHILADELPHIA (KYW Newsradio) — President Joe Biden announced on Wednesday he will invoke the Defense Production Act as families around the country continue to struggle to get the baby formula they so desperately need.

Biden said addressing the shortage is a top priority. Invoking the Defense Production Act would require suppliers to provide the baby formula manufacturers with the resources they need before sending the goods to other customers they may have. This tactic was used to speed up the production of the COVID-19 vaccine in 2021, and masks, ventilators and other medical supplies in 2020.

The president also announced an effort called “Operation Fly Formula”: “I’ve directed the Department of Defense and the Department of Health and Human Services to send aircraft, planes overseas to pick up infant formula that meets U.S. health and safety standards so we can get it onto store shelves faster.”

The Food and Drug Administration, on Monday, announced it would be more flexible when it comes to the baby formula that could be imported. Mexico, Ireland and the Netherlands provide the bulk of the formula that does come in. However, the FDA said the U.S. produces 98% of the formula that is consumed in the country.

Many families in the Philadelphia area and around the country are scrambling to find formula in stores. Some have taken to social media to share images of empty store shelves and tips on where they were able to find the product.

What’s causing the shortage?

The shortage of such an essential item has been caused by several factors. There are supply chain issues, similar to what other industries have been facing, but it goes beyond that.

“This is a deeper problem because only four companies account for about 90% of the entire market, which is making the supply chain extremely vulnerable,” Dr. Nilofar Varzgani, assistant professor of business systems and analytics at La Salle University, said on KYW Newsradio In Depth.

Listen to the full conversation below:

Podcast Episode
KYW Newsradio In Depth
'Four companies control 90%' How the baby formula industry failed to protect its Achilles' heel
Listen Now
Now Playing
Now Playing

One of those companies, Abbott, accounts for around 40% of the market share. The company voluntarily recalled its powdered infant formula and closed its manufacturing plant in Sturgis, Michigan, back in February. There were at least four complaints of Cronobacter sakazakii, a common environmental bacteria, in babies who consumed the powdered formula that was produced at the facility.

Abbott said two of the infants died, and two others became sick. The company maintains that after a review, there was no evidence to link its products to the illnesses.

The FDA and Abbott on Monday announced that the company agreed to take corrective actions so that the Michigan plant could reopen.

The company said production could start up again within two weeks, but it could take six to eight weeks after the restart for products to hit the shelves again.

LISTEN on the Audacy App
Sign Up and Follow Audacy
Facebook | Twitter | Instagram